#OnWatch: June 7, 2016
Stocks AMRS 0.65 - AMRS shares spiked Monday after news was issued about a research agreement with a commercial license option with Janssen Biotech to develop a customized library of natural and natural-like compounds to test against Janssen’s therapeutic target. Deals like this have come and AMRS shares have continued to fall into the lower range of the channel they have been in for roughly 9 months. Because of this and because these spikes will occur, bidding nearest to the 52 Wk [...]
